MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
34.35
+0.57
+1.67%
Opening 11:15 05/18 EDT
OPEN
33.66
PREV CLOSE
33.78
HIGH
35.07
LOW
33.66
VOLUME
71.78K
TURNOVER
--
52 WEEK HIGH
50.79
52 WEEK LOW
28.34
MARKET CAP
1.11B
P/E (TTM)
16.87
1D
5D
1M
3M
1Y
5Y
1D
Top 10 small‑cap value picks: lowest forward P/Es and strong profitability
Seeking Alpha · 11h ago
Weekly Report: what happened at COLL last week (0511-0515)?
Weekly Report · 12h ago
Have Collegium Pharmaceutical Insiders Been Selling Stock?
Simply Wall St · 1d ago
Collegium Shareholders Back Board, Pay and Auditor Choices
TipRanks · 2d ago
Collegium Pharmaceutical shareholders elect eight directors at annual meeting
PUBT · 3d ago
Collegium Pharma director Nancy Lurker disposes 4,500 shares for $161,861.06
PUBT · 3d ago
Analysts Offer Insights on Healthcare Companies: Aveanna Healthcare Holdings (AVAH), Collegium Pharmaceutical (COLL) and Dexcom (DXCM)
TipRanks · 3d ago
Statutory Profit Doesn't Reflect How Good Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are
Simply Wall St · 4d ago
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company. The Company has developed, licensed, and acquired a portfolio of products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. Its commercial products include Jornay PM (Jornay), Belbuca, Xtampza ER (Xtampza), Nucynta ER and Nucynta IR (Nucynta Products), and Symproic in the United States. Its Jornay is a central nervous system (CNS) stimulant prescription medicine for the treatment of ADHD. The Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. The Xtampza ER is a pain treatment option designed with abuse deterrent properties. Its portfolio also includes AZSTARYS (serdexmethylphenidate and dexmethylphenidate), a central nervous system (CNS) stimulant prescription medicine used for the treatment of ADHD in people six years of age and older.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.